GSK-113077

Study Sponsor: GSK

Study Title

Efficacy, safety and immunogenicity study of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A in adults aged 70 years or older

Medicine or Vaccine (generic name)

Herpes Zoster subunit (HZ/su) vaccine

Sponsor Identification Number

113077

Trial Registry Identification Number(#'s)

NCT01165229 2009-015791-94

Medical Condition

Herpes Zoster

Phase

Phase 3

Link to GSK Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

A nested study 204486 was conducted. There is a Publication Steering Committee for this study.

Date Added to this Site

April 2018